Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by Hvidovre University Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hvidovre University Hospital
ClinicalTrials.gov Identifier:
NCT00662181
First received: April 16, 2008
Last updated: April 18, 2008
Last verified: April 2008

April 16, 2008
April 18, 2008
May 2008
October 2008   (final data collection date for primary outcome measure)
Quality of life [ Time Frame: 6 months follow-up ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00662181 on ClinicalTrials.gov Archive Site
Metabolism [ Time Frame: 6 months follow-up ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Follow-up on the HIGH: Low Study - the Longterm Effect of Growth Hormone

A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.

Not Provided
Observational
Not Provided
Not Provided
Not Provided
Non-Probability Sample

Participants from the HIGH: low study

  • HIV Infections
  • HIV-Associated Lipodystrophy Syndrome
Not Provided
H, NH
HIV positive patients with and without lipodystrophy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
46
January 2009
October 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • over 18 years of age
  • Participated in and completed the HIGH: low study
  • informed consent signed

Exclusion Criteria:

  • Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study
Male
18 Years and older
No
Contact: Katrine MH Andersen, stud.med. 45-36-322-108 katrine.harries.andersen@hvh.regionh.dk
Denmark
 
NCT00662181
H-B-2008-053, 2008-41-2145
Yes
Forskningschef Ove Andersen, Klinisk Forskningscenter, Hvidovre Hospital
Hvidovre University Hospital
Not Provided
Principal Investigator: Ove Andersen, MD Klinisk Forskningcenter, Hvidovre Hospital
Hvidovre University Hospital
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP